278 papers found
Refreshing results…
Interaction Between Cyclosporine and Recipient Il-28b Rs12979860 C > T Genetic Polymorphisms In the Achievement of Sustained Viral Response For Recurrent Hepatitis C
Assembly Sequence Validation With an Augmented Realityauthoring Tool
Multi-Modal Hybrid Vehicle and Connection Device in a Hybrid Powertrain System
Interaction between cyclosporine and recipient IL-28B rs12979860 C>T genetic polymorphisms in the achievement of sustained viral response for recurrent hepatitis C
Is surgical restaging indicated in apparent stage IA pure ovarian dysgerminoma? The MITO group retrospective experience
579 the Presence of Diabetes Reduces Svr After Antiviral Therapy for Post-Transplant Hcv Recurrence
P.1.3: Acute and Chronic Rejection During Interferon Therapy in Hcv Recurrent Liver Transplant Patients: Results From the Aisf-Recolt-C Group
578 Is the Primary Immunosuppressive Drug (Cyclosporin a or Tacrolimus) Playing a Role on the Response to Antiviral Treatment for Post-Transplant Hcv Recurrence?
427 Treatment of Hepatitis C Recurrence After Liver Transplantation: Gender Issue on Therapy Outcome
551 Donor-Related Characteristics as Predictors of Sustained Virologic Response to Antiviral Therapy in Recurrent Hepatitis C After Liver Transplantation
561 Best Matching for Hcv Genotype 1 Liver Transplant Recipients Is Predicted by Hcv1-Star. A Study From Aisf Recolt-C Database
563 Acute and Chronic Rejection During Interferon Therapy in Hcv Recurrent Transplant Patients: Results Form the Aisf-Recolt-C Group
523 Protracted Antiviral Treatment Beyond Conventional Time Limits Improves Survival in Non-Responders to Interferon+ribavirin Administered for Hcv Recurrence After Liver Transplantation
464 TREATMENT OF THE “UNCOMMON” HCV GENOTYPE 4 INFECTION RECURRENCE AFTER LIVER TRANSPLANTATION. AN ITALIAN MULTICENTRIC EXPERIENCE
P.1.7: A SVR TO POST-LT ANTIVIRAL TREATMENT IMPROVES LONG-TERM SURVIVAL IN PATIENTS WITH GENOTYPE 1 HCV RECURRENCE: AN “AISF RECOLT-C” GROUP STUDY
P.1.5: Poor Adherence to Pegylated Interferon and Ribavirin Is a Major Concern in the Treatment of Recurrent Hepatitis C After Liver Transplantation: Evidence From the Aisf Recolt-C Study Group
Pc.1.4: The Best Matching for Hcv Genotype 1 Liver Transplant Recipients Is Predicted by Hcv1-Star. A Study From Aisf Recolt-C Database
P.1.54: TREATMENT OF THE “UNCOMMON” HCV GENOTYPE 4 INFECTION RECURRENCE AFTER LIVER TRANSPLANTATION. AN “AISF RECOLT-C” STUDY
P.1.2: The Persistence of Hcv Replication Is Associated With an Increased Mortality Rate in Hcv Recurrent Transplant Patients: Results From the Aisf-Recolt-C Group
532 Poor Adherence to Pegylated-Interferon and Ribavirin Is a Major Concern in the Treatment of Recurrent Hepatitis C After Liver Transplantation: Evidence From the Recolt-C Group
Missing publications? Read more about our data sources.